GlucoTrack (GCTK) Stock: Buy, Sell, or Hold?
GCTK - GlucoTrack, Inc. Common Stock
$0.60
-0.04 (-6.28%)
▼
5d:
-28.01%
30d:
-70.5%
90d:
+105.66%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 12, 2026
20d
Get Alerted When GCTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GCTK is down 28.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GCTK is down 28.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GCTK is currently trading at $0.60, which is considered oversold relative to its 30-day fair value range of $0.85 to $2.14.
Technical Outlook: Technically, GCTK is in a uptrend. Immediate support is located at $0.56, while resistance sits at $1.20. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GCTK is in a uptrend. Immediate support is located at $0.56, while resistance sits at $1.20. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.85 -
$2.14
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
68.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BEARISH: Downward momentum (-6.3%)
- WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.85 -
$2.14
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.56
Resistance Level
$1.20
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Share & Embed Analysis
Last updated: October 22, 2026 4:12 PM ET
Data refreshes hourly during market hours. Next update: 5:12 PM
Data refreshes hourly during market hours. Next update: 5:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GCTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 45 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 51 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 32 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 44 HOLD |
